[via AP]
Mylan wins tentative US approval for generic version of Lilly's Alimta — it could be years before it can be sold
Lilly may have fended off competition from a platoon of generic drug makers and their patent challenges on its chemotherapy Alimta, but that has not …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
